Category:Adam Castoreno of Framingham MA (US)

Adam Castoreno of Framingham MA (US)

Executive Summary

Adam Castoreno of Framingham MA (US) is an inventor who has filed 3 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (3 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (3 patents), of the backbone (2 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (3 patents). Their most frequent collaborators include (3 collaborations), (1 collaborations), (1 collaborations).

Patent Filing Activity

File:Adam Castoreno of Framingham MA (US) Monthly Patent Applications.png

Technology Areas

File:Adam Castoreno of Framingham MA (US) Top Technology Areas.png

List of Technology Areas

• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 3 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2310/315 (of the backbone): 2 patents
• A61P25/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N2310/312 (of the backbone): 1 patents
• C12N2310/321 (2'-O-R Modification): 1 patents
• C12N2310/322 (2'-R Modification): 1 patents
• A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents
• A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

File:Adam Castoreno of Framingham MA (US) Top Companies.png

List of Companies

• Alnylam Pharmaceuticals, Inc.: 3 patents

Collaborators

• Mark K. Schlegel of Boston MA (US) (3 collaborations)
• Lan Thi Hoang Dang of Arlington MA (US) (1 collaborations)
• Joseph Barry of Arlington MA (US) (1 collaborations)
• Tuyen M. Nguyen of Milton MA (US) (1 collaborations)
• Kawai So of Cambridge MA (US) (1 collaborations)
• James D. McIninch of Burlington MA (US) (1 collaborations)
• Elane Fishilevich of Rochester MA (US) (1 collaborations)
• Kristina Yucius of Burlington MA (US) (1 collaborations)
• William Cantley of Brighton MA (US) (1 collaborations)
• James D. Mclninch of Burlington MA (US) (1 collaborations)
• Bret Lee Bostwick of Cambridge MA (US) (1 collaborations)